RJF Stock Cash Flow Statements

Raymond James Financial Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Raymond James Financial Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2014-09-30	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31

cash flows from operating activities:
net income	436,000,000	495,000,000	600,000,000	602,000,000	492,000,000	476,000,000	498,000,000	434,000,000	369,000,000	427,000,000	509,000,000	439,000,000	301,000,000	323,000,000	446,000,000	429,000,000	307,000,000	355,000,000	312,000,000	209,000,000	172,000,000	169,000,000	268,000,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	49,000,000	47,000,000	47,000,000	47,000,000	45,000,000	45,000,000	42,000,000	42,000,000	42,000,000	41,000,000	40,000,000	40,000,000	36,000,000	34,000,000	35,000,000	37,000,000	33,000,000	32,000,000	32,000,000	31,000,000	30,000,000	28,000,000	30,000,000	31,000,000	28,000,000	27,000,000	26,000,000	26,805,000	25,145,000	23,496,000	23,289,000	21,983,000	21,190,000	21,018,000	19,941,000	18,419,000	18,312,000	17,743,000	17,909,000	17,264,000	17,122,000	16,005,000	13,366,000	18,026,000	10,082,000	9,971,000	10,007,000	10,528,000	19,792,426	9,574
deferred income taxes	-50,000,000	11,000,000	35,000,000	-55,000,000	-2,000,000	-17,000,000	-9,000,000	-66,000,000	-18,000,000	-29,000,000	25,000,000	-39,000,000	11,000,000	-2,000,000	14,000,000	-13,000,000	-51,000,000	9,000,000	18,000,000	-26,000,000	1,000,000	-30,000,000	16,000,000	-1,000,000	-21,000,000	-7,000,000	6,000,000	17,703,000	-6,342,000	-16,085,000	121,273,000	45,331,000	-18,767,000	-49,109,000	10,928,000	-24,941,000	-20,562,000	-19,926,000	6,631,000	565,000	2,250,000	-9,017,000	18,433,000	-6,356,000	411,000	-10,444,000	37,234,000	-17,394,000	-25,829,263	-18,737
premium and discount amortization on available-for-sale securities and bank loans and net unrealized gains/losses on other investments	-18,000,000
provisions for credit losses and legal and regulatory matters	83,000,000	17,000,000	7,000,000				7,000,000
share-based compensation expense	52,000,000	54,000,000	93,000,000	53,000,000	54,000,000	57,000,000	90,000,000	45,000,000	54,000,000	57,000,000	81,000,000	43,000,000	40,000,000	44,000,000	65,000,000	29,000,000	29,000,000	31,000,000	43,000,000	23,000,000	23,000,000	31,000,000	43,000,000	24,000,000	23,000,000	28,000,000	37,000,000	22,330,000	22,156,000	24,151,000	34,417,000	19,745,000	10,404,000	25,470,000	40,545,000	15,649,000	18,042,000	20,335,000	22,400,000	14,136,000	16,843,000	17,647,000	13,955,000	11,434,000	12,930,000	17,410,000
unrealized gains on corporate-owned life insurance policies, net of expenses
other	2,000,000	-10,000,000	31,000,000	4,000,000	14,000,000	12,000,000	-8,000,000	11,000,000	2,000,000	7,000,000	-10,000,000	24,000,000	15,000,000	11,000,000	-1,000,000	19,000,000	16,000,000	9,000,000	22,000,000	88,000,000	8,000,000	-13,000,000	9,000,000	4,000,000	6,000,000	30,000,000	11,000,000	3,188,000	8,300,000	7,666,000	5,693,000	11,403,000	20,196,000	3,423,000	-5,490,000	1,854,000	14,509,000	13,346,000	6,881,000	32,614,000	5,776,000	26,121,000	-355,000	12,779,000	-2,137,000	827,000	25,934,000	21,334,000	-1,314,766	-2,234
net change in:
collateralized agreements, net of collateralized financings	-292,000,000	-3,000,000	48,000,000	-394,000,000	355,000,000	166,000,000	143,000,000	148,000,000	-177,000,000	89,000,000	97,000,000	-47,000,000	-49,000,000	-66,000,000	125,000,000	149,000,000	-179,000,000	63,000,000	-62,000,000
loans (provided to) financial advisors, net of repayments	-92,000,000	-67,000,000	-35,000,000	-77,000,000	-80,000,000	-12,000,000	-54,000,000	-23,000,000	-18,000,000	9,000,000	25,000,000
brokerage client receivables and other receivables	-30,000,000	-471,000,000	331,000,000	147,000,000	60,000,000	-873,000,000	304,000,000	-199,000,000	311,000,000	-332,000,000	477,000,000	-146,000,000	242,000,000	-496,000,000	197,000,000
trading instruments	146,000,000	-3,000,000	-66,000,000	44,000,000	-21,000,000	-251,000,000	194,000,000	-95,000,000	-101,000,000	36,000,000	127,000,000	-78,000,000	-34,000,000	-49,000,000	209,000,000	-183,000,000	132,000,000	-112,000,000	22,000,000	-66,000,000			4,000,000	93,000,000	-16,000,000	-98,000,000	62,000,000	-54,298,000	77,400,000	-119,152,000	-46,547,000	-12,375,000	-104,598,000	-18,637,000	192,716,000	77,140,000	-81,610,000	-179,393,000	162,685,000	-5,455,000	11,778,000	-102,363,000	129,762,000	-71,539,000	51,365,000	-6,712,000	-18,894,000	13,357,000	86,210,886	66,114
derivative instruments	-85,000,000	-86,000,000	202,000,000	-186,000,000	120,000,000	81,000,000	-166,000,000	94,000,000	-102,000,000	-104,000,000	-18,000,000	233,000,000	80,000,000	108,000,000	58,000,000	12,000,000	-50,000,000	100,000,000	-9,000,000	17,000,000	-43,000,000	-77,000,000	52,000,000	-7,000,000	-44,000,000	-33,000,000	-60,000,000	-3,918,000	30,504,000	15,897,000	30,449,000
other assets	55,000,000	5,000,000	18,000,000	27,000,000	15,000,000	7,000,000	-40,000,000	-9,000,000	22,000,000	-73,000,000	8,000,000	-29,000,000	-58,000,000	392,000,000	-431,000,000	254,000,000	-215,000,000	507,000,000	-530,000,000	51,000,000	112,000,000	-95,000,000	-81,000,000	-2,000,000	35,000,000	-96,000,000	-22,000,000	76,183,000	454,000	-30,467,000	-18,799,000
brokerage client payables and other payables	293,000,000	-81,000,000	119,000,000	19,000,000	-511,000,000	422,000,000	161,000,000	-324,000,000	-872,000,000	-1,010,000,000	-3,882,000,000	-7,198,000,000	-3,571,000,000	1,535,000,000	5,021,000,000
accrued compensation, commissions and benefits	298,000,000	122,000,000	-529,000,000	345,000,000	219,000,000	263,000,000	-423,000,000	218,000,000	237,000,000	179,000,000	-511,000,000	185,000,000	17,000,000	117,000,000	-395,000,000	256,000,000	189,000,000	224,000,000	-253,000,000	231,000,000	179,000,000	0	-340,000,000	179,000,000	130,000,000	160,000,000	-389,000,000	183,534,000	104,970,000	109,518,000	-266,453,000	177,155,000	91,133,000	109,784,000	-218,034,000	151,015,000	64,232,000	73,919,000	-242,815,000	96,752,000	57,012,000	117,221,000	99,578,000	50,940,000	70,843,000	-161,374,000	17,153,000	71,694,000	-54,537,444	-122,556
purchases and originations of loans held for sale, net of proceeds from sales of securitizations and loans held for sale	-57,000,000	53,000,000	-67,000,000	-22,000,000	-24,000,000	102,000,000	-97,000,000	40,000,000	3,000,000	72,000,000	-66,000,000	51,000,000	135,000,000	-110,000,000	-43,000,000	-4,000,000	66,000,000	19,000,000	-86,000,000																	-39,575,000	1,600,000	10,898,000	-74,078,000		-23,577,000
net cash from operating activities	691,000,000	117,000,000	830,000,000							-624,000,000	-3,136,000,000	-4,498,000,000				4,501,000,000	1,408,000,000	-1,188,000,000	1,904,000,000			2,397,000,000	546,000,000			-205,000,000	225,000,000		2,116,000	661,414,000	325,619,000			284,364,000	807,775,000	-431,102,000	-19,372,000	-295,259,000	227,409,000	434,391,000	84,100,000	56,667,000	175,502,000	146,717,000	89,061,000	-19,991,000	468,286,000	-42,822,000	1,131,764,551	1,212,449
capex	-57,000,000	-46,000,000	-41,000,000							-42,000,000	-27,000,000	-23,000,000				25,000,000	-37,000,000	-37,000,000	-25,000,000			-35,000,000	-36,000,000			-32,000,000	-27,000,000		0	0	0			-44,679,000	-78,659,000	-35,215,000	-28,338,000	-25,599,000	-32,581,000	-22,446,000	-22,022,000	-16,045,000	-23,943,000	-22,390,000	-17,535,000	-13,647,000	-9,030,000	-12,196,000	-15,964,500	-9,500
free cash flows	634,000,000	71,000,000	789,000,000							-666,000,000	-3,163,000,000	-4,521,000,000				4,526,000,000	1,371,000,000	-1,225,000,000	1,879,000,000			2,362,000,000	510,000,000			-237,000,000	198,000,000		2,116,000	661,414,000	325,619,000			239,685,000	729,116,000	-466,317,000	-47,710,000	-320,858,000	194,828,000	411,945,000	62,078,000	40,622,000	151,559,000	124,327,000	71,526,000	-33,638,000	459,256,000	-55,018,000	1,115,800,051	1,202,949
cash flows from investing activities:
increase in bank loans	-1,710,000,000	-1,040,000,000	-1,294,000,000	-862,000,000	-1,267,000,000	-65,000,000	-405,000,000	-500,000,000	-141,000,000	205,000,000	-826,000,000	-1,858,000,000	-2,527,000,000	-1,713,000,000	-1,137,000,000	-1,407,000,000	-1,098,000,000	-818,000,000	-704,000,000	-158,000,000	88,000,000	-701,000,000	-365,000,000	-379,000,000	-447,000,000	-318,000,000	-461,000,000	-943,133,000	-637,573,000	-592,531,000	-645,197,000	-463,580,000	-686,549,000	-321,057,000	-782,388,000	-498,356,000	-489,306,000	-720,516,000	-770,371,000	-1,104,810,000	183,182,000	-582,459,000
proceeds from sales of loans held for investment	135,000,000	21,000,000	62,000,000	78,000,000	173,000,000	88,000,000	76,000,000	80,000,000	458,000,000	97,000,000	45,000,000	22,000,000	57,000,000	59,000,000	75,000,000	39,000,000	158,000,000	74,000,000	16,000,000	362,000,000	247,000,000	0	25,000,000	25,000,000	26,000,000	55,000,000	129,000,000	52,679,000	49,731,000	69,167,000	21,580,000	45,461,000	181,446,000	52,060,000	54,163,000	80,821,000	51,293,000	30,068,000	35,375,000	47,558,000	21,918,000	32,503,000
purchases of available-for-sale securities	-180,000,000	-92,000,000	-208,000,000	-106,000,000	-49,000,000	-297,000,000	-51,000,000	-50,000,000	-236,000,000	-172,000,000	-153,000,000	-326,000,000	-751,000,000	-1,168,000,000	-824,000,000	-1,137,000,000	-808,000,000	-1,030,000,000	-1,243,000,000	-2,563,000,000	-1,744,000,000	-1,089,000,000	-314,000,000	-338,000,000	-180,000,000	-218,000,000	-291,000,000	-224,960,000	-244,396,000	-315,267,000	-339,580,000	-308,084,000
available-for-sale securities maturations, repayments and redemptions	522,000,000	503,000,000	506,000,000	731,000,000	546,000,000	438,000,000	295,000,000	285,000,000	338,000,000	313,000,000	326,000,000	366,000,000	394,000,000	451,000,000	501,000,000	523,000,000	591,000,000	523,000,000	544,000,000	444,000,000	309,000,000	229,000,000	206,000,000	188,000,000	161,000,000	144,000,000	151,000,000	135,928,000	125,120,000	120,278,000	114,139,000	100,689,000
proceeds from sales of available-for-sale securities	0	0	78,000,000									50,000,000				0	450,000,000	0	519,000,000	0												28,118,000
additions to property and equipment	-57,000,000	-46,000,000	-41,000,000	-50,000,000	-56,000,000	-49,000,000	-50,000,000	-51,000,000	-53,000,000	-42,000,000	-27,000,000	-23,000,000	-26,000,000	-23,000,000	-19,000,000	25,000,000	-37,000,000	-37,000,000	-25,000,000	-27,000,000	-26,000,000	-35,000,000	-36,000,000	-36,000,000	-43,000,000	-32,000,000	-27,000,000						-29,507,000	-44,679,000	-78,659,000	-35,215,000	-28,338,000	-25,599,000	-32,581,000	-22,446,000	-22,022,000	-16,045,000	-23,943,000	-22,390,000	-17,535,000	-13,647,000	-9,030,000	-12,196,000	-15,964,500	-9,500
sales/(purchases) of federal reserve bank (“frb”) and federal home loan bank (“fhlb”) stock	-1,000,000
renewable energy tax credit equity investments
other investing activities	-11,000,000	-14,000,000	-40,000,000	5,000,000	4,000,000	-47,000,000	-26,000,000	-8,000,000	-17,000,000	-13,000,000	-31,000,000	-12,000,000	-10,000,000	-45,000,000	-26,000,000	-5,000,000	24,000,000	1,000,000	-12,000,000	-23,000,000	-21,000,000	8,000,000	-18,000,000	29,000,000	12,000,000	-8,000,000	-34,000,000	-6,777,000	49,858,000	12,026,000	-29,669,000	-1,212,000
net cash from investing activities	-1,302,000,000	-659,000,000	-937,000,000			67,000,000	-176,000,000			347,000,000	-666,000,000	-2,032,000,000	-2,716,000,000	-848,000,000	-1,555,000,000	-1,983,000,000	-720,000,000	-1,314,000,000	-1,123,000,000	-1,965,000,000	-930,000,000	-1,588,000,000	-502,000,000	-511,000,000	-476,000,000	-377,000,000	-533,000,000	-978,286,000	-682,936,000	-740,816,000	-1,073,876,000	-647,334,000	-793,734,000	-829,853,000	-1,105,149,000	-942,673,000	-435,386,000	-747,047,000	-856,713,000	-1,233,554,000	331,241,000	-529,336,000	-222,614,000	-1,456,008,000	-608,285,000	-444,308,000	-396,221,000	-105,477,000	101,577,002	-22,002
cash flows from financing activities:
increase in bank deposits	846,000,000			1,609,000,000	-442,000,000	-550,000,000	1,194,000,000		-461,000,000	2,250,000,000	622,000,000	1,469,000,000	2,610,000,000	593,000,000	1,597,000,000	2,155,000,000	1,086,000,000	1,464,000,000	989,000,000	1,429,000,000	-4,651,000,000	7,048,000,000	694,000,000	115,000,000	548,000,000	-55,000,000	1,731,000,000	462,946,000	766,658,000	-13,642,000	993,183,000	1,421,481,000	-66,663,000	1,187,754,000	927,243,000	530,353,000	1,002,737,000	71,848,000	737,728,000	909,265,000	-261,397,000	-238,914,000	322,409,000	363,458,000
repurchases of common stock and share-based awards withheld for payment of withholding tax requirements	-455,000,000	-274,000,000	-185,000,000	-329,000,000	-243,000,000	-213,000,000	-199,000,000		-302,000,000	-369,000,000	-189,000,000	-56,000,000	-101,000,000	-8,000,000	-51,000,000
dividends on common and preferred stock	-103,000,000	-106,000,000	-105,000,000	-95,000,000	-95,000,000	-96,000,000	-97,000,000
exercise of stock options and employee stock purchases	7,000,000	9,000,000	10,000,000	9,000,000	9,000,000	18,000,000	10,000,000		12,000,000	14,000,000	11,000,000	8,000,000	12,000,000	15,000,000	17,000,000	11,000,000	10,000,000	14,000,000	18,000,000	7,000,000	12,000,000	18,000,000	25,000,000	12,000,000	10,000,000	20,000,000	23,000,000	8,652,000	10,551,000	18,190,000	25,954,000	6,279,000	7,194,000	19,846,000	24,143,000	6,481,000	5,610,000	16,854,000	14,386,000	7,071,000	6,367,000	4,876,000	10,395,000	7,272,000	13,502,000	2,642,000	6,740,000	3,441,000	37,184,975	17,025
proceeds from fhlb advances	300,000,000	0	450,000,000	0
repayments of fhlb advances	-300,000,000	-200,000,000	-450,000,000
other financing	-3,000,000	2,000,000	-7,000,000	0	-1,000,000	0	-1,000,000		0	-1,000,000	-1,000,000	-2,000,000	0	0	-5,000,000	-3,000,000
net cash from financing activities						-641,000,000	907,000,000		-1,433,000,000	2,301,000,000	221,000,000	1,281,000,000	2,573,000,000	528,000,000	1,497,000,000	2,105,000,000	880,000,000	1,361,000,000	908,000,000	1,335,000,000	-4,693,000,000	7,297,000,000	654,000,000	-137,000,000	411,000,000	-427,000,000	1,526,000,000	378,078,000	730,037,000	-667,165,000	979,232,000	1,762,309,000	437,649,000	663,270,000	1,201,335,000	1,061,027,000	956,766,000	-88,470,000	649,410,000	816,610,000	-366,608,000	-163,276,000	296,138,000	163,564,000	1,477,504,000	-57,931,000	771,567,000	472,630,000	-2,920,653,890	-2,927,110
raymond james financial, inc. and subsidiaries condensed consolidated statements of cash flows
in millions	0	1,000,000	2,024,000,000		0	1,000,000	2,023,000,000		0	1,000,000	2,022,000,000	0	0	1,000,000	2,021,000,000	0	0	1,000,000	2,020,000,000	0	0	1,000,000	2,019,000,000	0	0	1,000,000	2,018,000,000
currency adjustment:
effect of exchange rate changes on cash and cash equivalents, including those segregated for regulatory purposes	197,000,000	65,000,000	-214,000,000		-11,000,000	-48,000,000	115,000,000		88,000,000	43,000,000	215,000,000
net increase/(decrease) in cash and cash equivalents, including those segregated for regulatory purposes and restricted cash	-122,000,000	-493,000,000	-768,000,000		-970,000,000	-231,000,000	1,389,000,000							745,000,000	-2,342,000,000
cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at beginning of year	0	0	14,348,000,000		0	0	12,548,000,000		0	0	14,659,000,000	0	0	0	16,449,000,000
cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of period	-122,000,000	-493,000,000	13,580,000,000		-970,000,000	-231,000,000	13,937,000,000		-1,146,000,000	2,067,000,000	11,293,000,000		5,357,000,000	745,000,000	14,107,000,000
cash and cash equivalents	-467,000,000	-386,000,000	10,048,000,000		-906,000,000	-205,000,000	10,206,000,000		-288,000,000	2,486,000,000	6,177,000,000	220,000,000	243,000,000	-2,501,000,000	8,216,000,000	1,219,000,000	131,000,000	474,000,000	5,377,000,000	-242,000,000	-5,016,000,000	6,539,000,000	4,109,000,000	361,000,000	-235,000,000	-491,000,000	4,322,000,000
cash and cash equivalents segregated for regulatory purposes and restricted cash	345,000,000	-107,000,000	3,532,000,000		-64,000,000	-26,000,000	3,731,000,000		-858,000,000	-419,000,000	5,116,000,000	-5,770,000,000	5,114,000,000	3,246,000,000	5,891,000,000
total cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of period	-122,000,000	-493,000,000	13,580,000,000		-970,000,000	-231,000,000	13,937,000,000		-1,146,000,000	2,067,000,000	11,293,000,000		5,357,000,000	745,000,000	14,107,000,000
supplemental disclosures of cash flow information:
cash paid for interest	446,000,000	449,000,000	499,000,000		526,000,000	550,000,000	499,000,000		375,000,000	267,000,000	216,000,000	186,000,000	61,000,000	35,000,000	41,000,000	32,000,000	37,000,000	41,000,000	35,000,000	46,000,000	26,000,000	53,000,000	39,000,000	75,000,000	61,000,000	85,000,000	62,000,000	73,859,000	43,297,000	55,746,000	28,026,000	63,054,000	15,940,000	44,548,000	32,442,000	27,888,000	30,142,000	29,188,000	26,421,000	25,926,000	27,307,000	25,116,000	40,046,000	15,096,000	25,096,000	11,215,000	19,145,000	3,622,000	32,556,213	8,787
cash paid for income taxes	137,000,000	364,000,000	9,000,000		175,000,000	349,000,000	24,000,000		147,000,000	376,000,000	13,000,000	138,000,000	93,000,000	281,000,000	12,000,000	102,000,000	87,000,000	181,000,000	67,000,000	44,000,000	26,000,000	167,000,000	9,000,000	95,000,000	107,000,000	178,000,000	10,000,000	39,376,000	109,087,000	74,158,000	8,515,000	105,424,000	98,913,000	130,962,000	13,710,000	93,004,000	86,268,000	90,604,000	33,917,000	66,997,000	102,360,000	61,068,000	52,824,000	13,227,000	100,351,000	10,137,000	39,958,000	35,525,000	118,743,312	6,688
cash outflows for lease liabilities	33,000,000	33,000,000	33,000,000		31,000,000	30,000,000	30,000,000		32,000,000	29,000,000	31,000,000	31,000,000	28,000,000	27,000,000	25,000,000	26,000,000	28,000,000	29,000,000	27,000,000
non-cash right-of-use assets recorded for new and modified leases	24,000,000	21,000,000	33,000,000		26,000,000	8,000,000	17,000,000		70,000,000	29,000,000	13,000,000	29,000,000	13,000,000	10,000,000	16,000,000
unrealized (gains)/losses on company-owned life insurance policies, net of expenses
proceeds from short-term borrowings
net cash provided by/(used in) financing activities		-16,000,000	-447,000,000
premium and discount amortization on available-for-sale securities and bank loans and net unrealized gain/loss on other investments			-4,000,000	-6,000,000	-13,000,000	-5,000,000	-12,000,000	-12,000,000	-14,000,000	-12,000,000	-11,000,000
unrealized gain on company-owned life insurance policies, net of expenses					-12,000,000	-75,000,000	-87,000,000				-48,000,000				-38,000,000	9,000,000			-83,000,000	-36,000,000				-1,000,000
increase/(decrease) in bank deposits			-160,000,000
adjustments to reconcile net income to net cash provided by/(used in) operating activities:
provisions for credit losses and legal and regulatory proceedings									113,000,000										16,000,000
unrealized (gain)/loss on company-owned life insurance policies, net of expenses								29,000,000	-39,000,000			38,000,000	117,000,000									111,000,000	-35,000,000			-50,000,000	58,000,000
assets segregated for regulatory purposes excluding cash and cash equivalents												1,999,000,000	8,395,000,000	-795,000,000	-7,499,000,000
net cash provided by/(used in) operating activities				510,000,000	711,000,000	391,000,000	543,000,000	434,000,000						1,117,000,000	-2,287,000,000									678,000,000								-108,479,000
cash and cash equivalents acquired in business acquisitions, including those segregated for regulatory purposes, net of cash paid for acquisitions												-308,000,000	98,000,000
(purchases)/sales of federal reserve bank (“frb”) and federal home loan bank (“fhlb”) stock
investment in note receivable												0	0	0	-125,000,000
(purchases)/sales of other investments												57,000,000
redemption of preferred stock
repayments of fhlb advances and other borrowed funds				0
sales of federal reserve bank (“frb”) and federal home loan bank (“fhlb”) stock
investment in solar tax credit equity investment					0	0	-15,000,000
purchases of other investments									0
net cash provided by/(used in) investing activities
purchases of federal reserve bank and federal home loan bank stock
proceeds from federal home loan bank advances						0	750,000,000		900,000,000	1,000,000,000	650,000,000	0	175,000,000							0	0	0	850,000,000	0				0				100,000,000	750,000,000	0	100,000,000	0	0	0	25,000,000
repayments of federal home loan bank advances and other borrowed funds						0	-750,000,000		-1,450,000,000	-500,000,000	-791,000,000	-61,000,000	-54,000,000	-851,000,000	-1,000,000	-2,000,000	-1,000,000	-2,000,000	-26,000,000	-1,000,000	-1,000,000	-2,000,000	-851,000,000	-1,000,000			-1,000,000	-1,266,000			-1,186,000	-1,186,000	-651,170,000	-1,153,000	-1,138,000	-1,120,000	-1,106,000
provisions/(benefits) for credit losses and legal and regulatory proceedings											21,000,000	39,000,000	56,000,000	24,000,000	-8,000,000	9,000,000	-15,000,000
losses on extinguishment of debt																0
purchase of federal reserve bank stock
purchases of federal home loan bank stock
raymond james financial, inc. and subsidiaries
sales of federal home loan bank stock
dividends on preferred and common stock									-92,000,000	-93,000,000	-81,000,000
common stock issued as consideration for tristate capital acquisition												0
restricted stock awards issued as consideration for tristate capital acquisition												0
preferred stock issued as consideration for tristate capital acquisition
effective settlement of note receivable for tristate capital acquisition												0
purchase of federal home loan bank stock
net decrease in cash and cash equivalents, including those segregated for regulatory purposes and restricted cash										2,067,000,000	-3,366,000,000
loans provided to financial advisors, net of repayments												-35,000,000	-9,000,000	-20,000,000	-56,000,000	-21,000,000	-58,000,000	-16,000,000	5,000,000	-26,000,000	-12,000,000	1,000,000	-12,000,000	-51,000,000	-29,000,000			-10,300,000	-50,553,000	-396,000	-21,928,000	-11,449,000	-8,391,000	-20,432,000	-13,513,000	-244,600,000	-29,350,000	-32,336,000	-38,500,000		-21,789,000
raymond james financial, inc. and subsidiaries consolidated statements of cash flows
proceeds from senior notes issuances, net of debt issuance costs paid																0				0	-1,000,000
extinguishment of senior notes payable																0																-658,282,000
cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of year
total cash and cash equivalents, including those segregated for regulatory purposes and restricted cash at end of year
premium and discount amortization on available-for-sale securities and net (gain)/loss on other investments													16,000,000	10,000,000	14,000,000
dividends on common stock													-69,000,000	-71,000,000	-60,000,000	-55,000,000	-54,000,000	-54,000,000	-55,000,000	-51,000,000	-51,000,000	-52,000,000	-51,000,000	-48,000,000	-48,000,000	-48,000,000	-47,000,000	-44,121,000	-36,587,000	-38,129,000	-32,499,000	-31,880,000	-32,295,000	-31,772,000	-31,255,000	-28,438,000	-28,845,000	-29,046,000	-27,106,000	-26,028,000	-27,710,000	-22,660,000	-18,127,000	-17,777,000	-16,479,000	-16,399,000	-13,744,000	-16,478,000	-32,851,613	-16,387
effect of exchange rate changes on cash													-240,000,000	-52,000,000	3,000,000	-38,000,000	21,000,000	20,000,000	73,000,000	28,000,000	55,000,000	-103,000,000	21,000,000	-11,000,000	19,000,000	24,000,000	-55,000,000	6,585,000	-9,404,000	-11,024,000	-3,118,000	47,697,000	12,962,000	-9,730,000	-26,138,000	-14,857,000	-3,737,000	14,174,000	-24,724,000	1,478,000	-6,789,000	-10,749,000	1,959,000	-1,096,000	624,000	-511,000	-2,625,000	823,000	979,693	-1,693
net increase in cash and cash equivalents, including those segregated for regulatory purposes and restricted cash
issuance of preferred stock as consideration for tristate capital acquisition
business acquisitions, net of cash acquired																-21,000,000	0	-27,000,000	-218,000,000
premium and discount amortization on available-for-sale securities and net gain/loss on other investments
goodwill impairment
purchases of treasury stock																-1,000,000	-48,000,000	-61,000,000	-18,000,000	-50,000,000	0	-203,000,000	-19,000,000	-162,000,000	-95,000,000	-41,000,000	-480,000,000	-38,183,000	-1,202,000	-2,343,000	-20,243,000	-1,876,000	-3,116,000	-3,005,000	-26,058,000	-1,001,000	-2,326,000	-147,036,000	-12,139,000	-57,652,000	-16,013,000
proceeds from borrowings on the rjf credit facility																								0	0	0	300,000,000	0	0	0	300,000,000
repayment of borrowings on the rjf credit facility																												0	0
premium and discount amortization on available-for-sale securities and loss on other investments																	-2,000,000	15,000,000	-1,000,000	4,000,000	10,000,000	35,000,000	8,000,000				3,000,000
assets segregated pursuant to regulations excluding cash and cash equivalents																	2,250,000,000	-2,501,000,000	-2,749,000,000
brokerage client receivables and other accounts receivable																	-302,000,000	-377,000,000	254,000,000	1,000,000	329,000,000	-391,000,000	188,000,000	17,000,000	92,000,000	141,000,000	446,000,000	-373,135,000	-23,718,000	-249,031,000	123,512,000	24,965,000	-99,115,000	-68,177,000	91,410,000	-566,535,000	86,929,000	-388,553,000	246,998,000	-53,304,000	-262,972,000	-149,647,000		-297,824,000	-87,975,000	69,322,000	162,452,000	-87,369,000	-157,292,147	46,147
brokerage client payables and other accounts payable																	-798,000,000	518,000,000	4,953,000,000	865,000,000	-1,316,000,000	2,472,000,000	465,000,000	69,000,000	-212,000,000	-846,000,000	-242,000,000	529,742,000	-954,025,000	303,516,000	466,763,000	-484,084,000	-217,940,000	76,303,000	-507,562,000	1,219,188,000	-34,392,000	555,888,000	76,620,000	462,762,000	74,902,000	183,916,000	-340,578,000	-167,311,000	-58,509,000	141,531,000	929,177,000	-7,640,000	390,588,220	66,780
net increase in cash and cash equivalents, including those segregated pursuant to regulations																	1,589,000,000	-1,121,000,000	1,762,000,000
cash and cash equivalents, including those segregated pursuant to regulations at beginning of year																	0	0	9,634,000,000
cash and cash equivalents, including those segregated pursuant to regulations at end of period																	1,589,000,000	-1,121,000,000	11,396,000,000
cash and cash equivalents segregated pursuant to regulations																	1,458,000,000	-1,595,000,000	6,019,000,000	1,039,000,000	-840,000,000	1,464,000,000	2,581,000,000
total cash and cash equivalents, including those segregated pursuant to regulations at end of period																	1,589,000,000	-1,121,000,000	11,396,000,000
non-cash right-of-use (“rou”) assets recorded for new and modified leases																	20,000,000	31,000,000	50,000,000
acquisitions of and distributions to noncontrolling interests																				1,000,000				-3,000,000
provisions for loan losses, legal and regulatory proceedings and bad debts																				48,000,000	85,000,000	123,000,000	1,000,000	14,000,000	7,000,000	6,000,000	32,000,000	21,004,000	19,777,000	4,637,000	9,265,000
raymond james financial, inc. and subsidiariesconsolidated statements of cash flows
repayments of short-term borrowings																																							-115,000,000
acquisition-related contingent consideration paid
net increase/(decrease) in cash and cash equivalents and cash and cash equivalents segregated pursuant to regulations
cash and cash equivalents and cash and cash equivalents segregated pursuant to regulations at beginning of year																				0	0	0	5,971,000,000
cash and cash equivalents and cash and cash equivalents segregated pursuant to regulations at end of year
total cash and cash equivalents and cash and cash equivalents segregated pursuant to regulations at end of year
securities purchased under agreements to resell, net of securities sold under agreements to repurchase																					-47,000,000	205,000,000	68,000,000		-8,000,000	7,000,000	-60,000,000	42,284,000	76,758,000	-228,749,000	104,290,000
securities loaned, net of securities borrowed																					10,000,000	-250,000,000	-47,000,000					-54,779,000	81,489,000	35,173,000	-140,229,000	-32,277,000
proceeds from sales of securitizations and loans held for sale, net of purchases and originations of loans held for sale																					41,000,000	82,000,000	-91,000,000		4,000,000	-25,000,000	48,000,000		-26,290,000	69,641,000	-108,470,000	144,863,000	-33,396,000	42,603,000	35,162,000							-3,609,000
business acquisition, net of cash acquired																													0	0	-159,200,000											0	23,010,000
repayments of borrowings on the rjf credit facility
net increase in cash and cash equivalents and cash and cash equivalents segregated pursuant to regulations																					-5,856,000,000	8,003,000,000	719,000,000
cash and cash equivalents and cash and cash equivalents segregated pursuant to regulations at end of period																					-5,856,000,000	8,003,000,000	6,690,000,000
total cash and cash equivalents and cash and cash equivalents segregated pursuant to regulations at end of period																					-5,856,000,000	8,003,000,000	6,690,000,000
raymond james financial, inc. and subsidiariescondensed consolidated statements of cash flows
distributions to noncontrolling interests																												-3,062,000	-8,121,000	-3,000	-5,977,000	-3,601,000
proceeds from/(repayments of) short-term borrowings																							6,000,000							-330,000,000	-280,000,000
premium and discount amortization on available-for-sale securities and (gain)/loss on other investments
securities sold under agreements to repurchase, net of securities purchased under agreements to resell
jay peak matter payments
proceeds from senior note issuances, net of debt issuance costs paid																																-16,000
premium paid on extinguishment of senior notes payable
acquisition-related contingent consideration (paid)/received
net increase/(decrease) in cash, cash equivalents, and cash segregated pursuant to regulations																								19,000,000	-167,000,000
cash, cash equivalents, and cash segregated pursuant to regulations at beginning of year																								0	0	0	5,941,000,000
cash, cash equivalents, and cash segregated pursuant to regulations at end of year
cash segregated pursuant to regulations																								-342,000,000	68,000,000	-494,000,000	2,782,000,000
total cash, cash equivalents, and cash segregated pursuant to regulations at end of year
net income attributable to raymond james financial, inc.																									259,000,000	261,000,000	249,000,000	262,748,000	232,258,000	242,847,000	118,842,000	193,489,000	183,424,000	112,755,000	146,567,000	171,670,000	125,504,000	125,847,000	106,329,000	129,186,000	133,195,000	136,366,000	83,325,000	76,350,000	68,869,000	67,325,000	68,927,000	46,786,000	162,558,277	81,723
net income attributable to noncontrolling interests																									-2,000,000	-12,000,000	-2,000,000				441,000			-4,210,000	1,136,000	-2,880,000	-6,315,000	-7,914,000	-6,163,000	-5,681,000	-6,835,000	-7,210,000	-6,927,000	13,121,000	-3,595,000	-6,203,000	-7,147,000	2,412,000	-5,763,232	-3,768
net income including noncontrolling interests																									257,000,000	249,000,000	247,000,000	256,827,000	232,242,000	242,565,000	119,283,000	197,268,000	185,351,000	108,545,000	147,703,000	168,790,000	119,189,000	117,933,000	100,166,000	123,505,000	126,360,000	129,156,000	76,398,000	89,471,000	65,274,000	61,122,000	61,780,000	49,198,000	156,795,045	77,955
adjustments to reconcile net income including noncontrolling interests to net cash from operating activities:
securities borrowed, net of securities loaned																									-363,000,000	297,000,000	22,000,000
cash, cash equivalents, and cash segregated pursuant to regulations at end of period																									-167,000,000	-985,000,000	7,104,000,000
total cash, cash equivalents, and cash segregated pursuant to regulations at end of period																									-167,000,000	-985,000,000	7,104,000,000
repayments of other borrowed funds																																							-1,091,000
see accompanying notes to condensed consolidated financial statements (unaudited).
net increase in cash, cash equivalents, and cash segregated pursuant to regulations																											1,163,000,000
net income/(loss) attributable to noncontrolling interests																												-5,921,000	-16,000
adjustments to reconcile net income including noncontrolling interests to net cash provided by/(used in) operating activities:
compensation expense/(benefit) payable in common stock of an acquiree																												2,282,000	-3,577,000
see accompanying notes to consolidated financial statements.
in thousands																												0	0	1,000	2,017,000
net increase/(decrease) in cash and cash equivalents																												320,555,000	39,813,000			1,054,193,000
cash and cash equivalents at beginning of year																												0	0	0	3,669,672,000	0	0	0	1,650,452,000	0	0	0	2,601,006,000	0	0	0	0	0	0	2,439,695,000	0	0	2,940,295,761	2,943,239
cash and cash equivalents at end of year
premium and discount amortization on available-for-sale securities and loss/(gain) on other investments
unrealized gain on company owned life insurance, net of expenses																													-4,925,000	2,127,000	-16,859,000
assets segregated pursuant to regulations and other segregated assets																													384,182,000	477,923,000	-96,759,000	-60,631,000	436,599,000	38,392,000	1,016,538,000	-1,190,414,000	-54,178,000	-538,128,000	-171,359,000	-392,238,000	47,363,000	-190,746,000	-65,173,000	864,538,000	46,829,000	43,490,000	-1,050,471,000	-91,343,000	1,024,219,623	1,363,377
additions to property, buildings and equipment, including software																													-25,676,000	-34,489,000	-35,949,000
acquisition-related contingent consideration received, net of payments																																0
cash and cash equivalents at end of period																													39,813,000	-757,591,000	3,897,529,000		-20,847,000	108,051,000	2,528,275,000		498,271,000	-1,116,602,000	2,596,388,000		41,944,000			-1,146,823,000	958,904,000	1,916,954,000		343,520,000	1,253,963,117	1,204,883
premium and discount amortization on available-for-sale securities and unrealized gain on other investments																														-4,818,000	-496,000	-4,104,000
compensation expense payable in common stock of an acquiree																															3,925,000
net increase in cash and cash equivalents																															227,857,000			108,051,000	877,823,000	-327,605,000	498,271,000	-1,116,602,000	-4,618,000	18,925,000	41,944,000	-646,694,000
provisions for loan losses, legal and regulatory proceedings (excluding the jay peak matter) and bad debts
compensation expense/(benefit) which is payable in common stock of an acquiree
unrealized (gain)/loss on company owned life insurance, net of expenses
loss on extinguishment of senior notes payable
securities purchased under agreements to resell and other collateralized financings, net of securities sold under agreements to repurchase																																76,856,000	55,900,000	-157,633,000	121,878,000	-98,339,000	59,531,000	-78,232,000	-18,345,000	23,139,000	27,373,000	19,560,000	-16,885,000	-199,141,000	13,262,000	-6,892,000	195,917,000	-77,335,000	-216,599,882	-178,118
purchases of federal home loan bank/federal reserve bank stock																																-4,250,000	-4,250,000	-625,000	-4,250,000	0	0	-2,168,000	-1,063,000
proceeds from sales of or distributions received from private equity and other investments, net of purchases or contributions to private equity or other investments
compensation expense which is payable in common stock of an acquiree
prepaid expenses and other assets																																	-23,978,000	73,018,000	85,740,000	68,789,000	-170,698,000	54,158,000	75,873,000	47,237,000	-29,143,000	19,216,000	7,188,000	-21,987,000	46,049,000	-18,336,000	4,104,000	-28,642,000	11,120,129	-129
purchases, or contributions to private equity or other investments, net of proceeds from sales of, or distributions received from, private equity and other investments
repayment of senior notes payable																																	0			0
non-cash transfers of loans to other real estate owned																																	2,582,000	1,586,000	1,191,000	775,000	968,000	1,334,000	608,000	1,324,000	893,000	2,582,000	1,532,000	167,000	8,303,000	2,651,000	2,041,000	2,221,000	9,929,083	6,917
premium and discount amortization on available for sale securities and unrealized/realized gain on other investments																																		-8,791,000	-10,185,000	-6,726,000	-14,432,000	-6,439,000	2,587,000	100,000	-21,366,000	-1,071,000	-14,240,000	-7,797,000	-12,033,000	-1,392,000	-1,243,000	-10,089,000	-1,668,516	-484
provisions for loan losses, legal proceedings, bad debts and other accruals																																		110,976,000	33,017,000	11,372,000	-7,933,000	16,367,000	22,588,000	14,356,000	-2,391,000	11,190,000	5,926,000	17,041,000	3,082,000	6,556,000	8,514,000	14,105,000	30,005,207	14,793
stock loaned, net of stock borrowed																																		-2,389,000	-233,019,000	8,142,000	11,439,000	67,161,000	65,959,000	81,895,000	44,034,000	-23,826,000	-29,811,000	-85,196,000	-92,376,000	-150,573,000	188,507,000	101,037,000	-136,173,296	-122,704
purchases, or contributions, to private equity or other investments, net of proceeds from sales of, or distributions received from, private equity and other investments																																		34,531,000	16,924,000		23,212,000	-35,511,000	-25,128,000
purchases of available for sale securities																																		-635,003,000	-377,235,000	-354,271,000	-21,255,000	-10,453,000	-77,223,000	-88,284,000		0	2,000	-137,497,000	-110,934,000	-950,000	-236,440,000	-496,000	-1,830,799	-1,201
available for sale securities maturations, repayments and redemptions																																		59,329,000	56,647,000	30,238,000	22,994,000	21,102,000	21,627,000	17,848,000	18,054,000	18,395,000	27,329,000	84,480,000	21,351,000	40,029,000
proceeds from sales of available for sale securities																																		25,533,000	7,308,000	9,532,000	0			1,000	84,737,000	22,474,000
other investing activities, net of proceeds received																																		58,000	2,341,000	2,786,000
proceeds from (repayments of) short-term borrowings																																		-158,400,000	208,400,000
(excess tax benefit) reduction of prior tax benefit from share-based payment arrangements																																				-330,000
purchases or contributions, to private equity or other investments, net of proceeds from sales of, or distributions received from, private equity and other investments
(repayments of) proceeds from short-term borrowings
proceeds from senior note issuances, net of debt issuance costs
repayments of borrowings by consolidated variable interest entities which are real estate partnerships																																				1,000	-7,104,000	0	-7,159,000	30,000	-9,800,000	0	2,000	-11,547,000	-1,000	-11,599,000
proceeds from capital contributed to and borrowings of consolidated variable interest entities which are real estate partnerships																																								0	0	0	0	30,445,000	-20,977,000	21,078,000
excess tax benefit (reduction of prior tax benefit) from share-based payments																																				330,000
excess tax benefits from share-based payment arrangements																																						0	-34,791,000			710,000	-5,614,000	791,000	535,000	1,675,000
investments in real estate partnerships held by consolidated variable interest entities, net of other investing activity																																						-5,500,000	-7,349,000		12,271,000	1,000	-659,000	-471,000	156,000	174,000
(repayments) proceeds of short-term borrowings
excess tax benefits from share-based payments																																						0	34,791,000
goodwill impairment expense
(loans provided to) repayment of loans, to financial advisors
(purchases and originations of loans held for sale)/proceeds from sales of securitizations and loans held for sale
reduction of prior tax benefits/(excess tax benefits) from share-based payment arrangements
(purchases or contributions to private equity or other investments)/proceeds from sales of or distributions received from private equity and other investments
(repayments of)/proceeds from short-term borrowings
proceeds from federal home loan bank advances and other borrowed funds
purchase of additional equity interest in subsidiary																																											0	0	0	-4,017,000
(reduction of prior tax benefits)/excess tax benefits, from share-based payments
(excess tax benefits) reduction of prior tax benefits from share-based payment arrangements
purchases of federal home loan bank/federal reserve bank stock, net of redemptions
proceeds from sales of, or distributions received from, private equity, and other investments, net of purchases, business acquisitions or contributions to private equity or other investments
proceeds from borrowed funds																																									965,000	95,800,000	107,184,000				0
repayments of borrowed funds																																									-44,495,000	-1,035,000	-124,966,000
excess tax benefits (reduction of prior tax benefits) from share-based payments
(purchases)/redemptions of federal home loan bank/federal reserve bank stock
(purchases of or contributions to)/sales proceeds or distributions received from, private equity and other investments
(purchases) redemptions of federal home loan bank/federal reserve bank stock																																										-300,000
sales (purchases) of private equity and other investments																																														3,845,000	15,707,000	-3,825,000
proceeds from issuance of shares in registered public offering																																											0	591,000
purchase of treasury stock																																											-371,000	-1,267,000	-2,168,000	-17,054,000	-16,113,000	-82,000	-6,910,739	-5,261
(loans provided to) repayments of loans, to financial advisors
sales of private equity and other investments
loans to financial advisors, brokerage client receivables and other accounts receivable
purchase and origination of loans held for sale, net of proceeds from sale of securitizations and loans held for sale																																											31,057,000	-59,570,000	22,499,000	-12,822,000	-64,560,000	-54,488,000	-19,508,132	-2,868
increase in loans																																											-195,413,000	-294,310,000	-471,738,000	-489,970,000	-222,162,000			-48,760
redemptions (purchases) of federal home loan bank/federal reserve bank stock
(purchases) sales of private equity and other investments																																											-63,820,000	-10,526,000
decrease in securities purchased under agreements to resell
acquisition of controlling interest in subsidiary																																															0
increase in cash resulting from the consolidation of an acquired entity and the acquisition of a controlling interest in a subsidiary
loss benefit from auction rate securities
excess tax benefits from stock-based payment arrangements																																												-791,000	-535,000	-1,675,000		-703,000	-1,068,707	-293
redemptions of federal home loan bank stock																																														20,228,000
net decrease in cash and cash equivalents																																														-522,741,000		325,154,000	-1,686,332,644	-1,738,356
(purchases) redemptions of federal home loan bank stock
proceeds from (repayments of) borrowed funds
repayments of borrowings																																														-3,848,000	-831,000	-1,891,000	-2,556,074,205	-2,527,795
decrease in bank deposits																																														-34,426,000		233,875,000	-368,737,678	-397,322
redemptions (purchases) of federal home loan bank stock
decrease (increase) in securities purchased under agreements to resell
investments in real estate partnerships held by variable interest entities, net of other investing activity																																															-1,001,000	-9,722,000	-2,321,631	-4,369
increase in cash resulting from the consolidation/deconsolidation of certain entities
stock-based compensation expense																																																5,928,000	27,025,168	15,832
redemption of federal home loan bank stock																																																38,034,000	4,772,223	4,777
available for sale securities maturations and repayments																																																25,434,000	66,580,462	34,538
sales of available for sale securities																																																2,323,000	11,432,839	11,161
repayments of borrowings by variable interest entities which are real estate partnerships																																																-11,820,000	-11,847,141	-11,859
proceeds from capital contributed to variable interest entities which are real estate partnerships																																																15,384,000	17,513,804	14,196
decrease in loans
purchases of private equity and other investments																																																		-8,648
decrease (increase) in loans
(purchase) redemption of federal home loan bank stock
proceeds from borrowings by variable interest entities which are real estate partnerships
cash increased (reduced) by consolidation/deconsolidation of certain partnerships and other entities

We provide you with 20 years of cash flow statements for Raymond James Financial stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Raymond James Financial stock. Explore the full financial landscape of Raymond James Financial stock with our expertly curated income statements.

The information provided in this report about Raymond James Financial stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.